Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.

Matthew J LimAya AghaAnnie ImAnastasios RaptisJing Z HouMichael BoyiadzisAlison R SehgalRobert L RednerKathleen DorritieStanley S MarksMounzer E AghaSeah H Lim

Published in: Hematological oncology (2017)

Keyphrases

newly diagnosed
acute myeloid leukemia
end stage renal disease
chronic kidney disease
prognostic factors
peritoneal dialysis
squamous cell carcinoma
patient reported outcomes